Four Additional IPRs Filed By Merck Challenging The Johns Hopkins University Pembrolizumab Patents - Patent

On March 13, 2024, Merck Sharp & Dohme, LLC ("Merck") filed four additional IPRs challenging The Johns Hopkins University ("JHU") patents covering methods of treatment using pembrolizumab...

Related Keywords

Delaware ,United States ,Buchanan Ingersoll Rooney ,Lowenstein Sandler ,Cowan Liebowitz Latman ,Axinn Veltrop Harkrider ,Foley Lardner ,Bookoff Mcandrews ,Trademark Office ,Freshub Inc ,Intellectual Property ,Trademark Trial ,Appeal Board ,United States Patent ,Federal Circuit ,Mondaq ,Four Additional Iprs Filed By Merck Challenging The Johns Hopkins University Pembrolizumab Patents ,Food ,Drugs ,Healthcare ,Life Sciences ,Iotechnology Amp Nanotechnology ,Patent , ,